4145-98-6 Usage
Common Uses
Industrial: Used in various industrial applications.
Pharmaceutical: Utilized as a reagent in organic synthesis for pharmaceutical production.
Agrochemicals: Employed in the synthesis of agrochemicals.
Precursor for Manufacturing
Rubber Chemicals: Used in the production of rubber chemicals.
Dyes: Employed as a precursor in dye manufacturing.
Antioxidants: Used in the synthesis of antioxidants.
Biological and Pharmacological Properties
Enzyme Inhibition: Studied for its ability to inhibit enzymes.
Potential Therapeutic Use: Investigated for its potential in treating certain medical conditions.
Significance
Versatile Applications: Plays a significant role in various industries.
Research Interest: Due to its potential therapeutic properties, it attracts research attention in pharmacology and related fields.
Check Digit Verification of cas no
The CAS Registry Mumber 4145-98-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,1,4 and 5 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 4145-98:
(6*4)+(5*1)+(4*4)+(3*5)+(2*9)+(1*8)=86
86 % 10 = 6
So 4145-98-6 is a valid CAS Registry Number.
4145-98-6Relevant articles and documents
Gene delivery mediated by liposome-DNA complex with cleavable PEG surface modification
-
, (2008/06/13)
A liposome composition and method for delivery of a nucleic acid in vivo or ex vivo is described. The liposomes in the composition are comprised of (i) a cationic lipid and (ii) a lipid joined to a hydrophilic polymer by a releasable linkage. The liposomes are associated with a nucleic acid for delivery to a cell.
Releasable linkage and compositions containing same
-
, (2008/06/13)
A compound comprised of a hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage is described.
Process for producing cysteamines and/or cystamines
-
, (2008/06/13)
Specific cysteamines and/or cystamines are produced by a process which comprises causing (A) an aminoalkyl sulfate ester and (B) hydrogen sulfide and an alkali polysulfide formed from an alkali hydrogen sulfide and sulfur to react.
